UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective NaV1.8 Inhibitor, in Healthy Male Adults

Pain medicine (Malden, Mass.), 2021-08, Vol.22 (8), p.1814-1826

2021

Volltextzugriff (PDF)

A phase I, randomized, double‐blind, placebo‐controlled, single‐ and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX‐128, a highly selective Nav1.8 inhibitor, in healthy adults

Clinical and translational science, 2022-04, Vol.15 (4), p.981-993

2022

Volltextzugriff (PDF)

Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABAA partial agonist, in humans

British journal of anaesthesia : BJA, 2019-08, Vol.123 (2), p.e194-e203

2019

Volltextzugriff (PDF)

Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugs

European journal of pain, 2019-07, Vol.23 (6), p.1129-1140

2019

Volltextzugriff (PDF)

A phase I, randomized, double-blind, placebo-controlled, single- and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX-128, a highly selective Na v 1.8 inhibitor, in healthy adults

Clinical and translational science, 2022-04, Vol.15 (4), p.981-993

2022

Volltextzugriff (PDF)

The ultraviolet B inflammation model: Postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjects

European journal of pain, 2019-05, Vol.23 (5), p.874-883

2019

Volltextzugriff (PDF)

A split‐face comparative performance evaluation of injectable hyaluronic acid‐based preparations HCC and CPM‐HA20G in healthy females

Journal of cosmetic dermatology, 2022-11, Vol.21 (11), p.5576-5583

2022

Volltextzugriff (PDF)

Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteers

British journal of clinical pharmacology, 2022-06, Vol.88 (6), p.2909-2925

2022

Volltextzugriff (PDF)

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective [Na.sub.V]18 Inhibitor, in Healthy Male Adults

Pain medicine (Malden, Mass.), 2021-08, Vol.22 (8), p.1814

2021

Volltextzugriff (PDF)

Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABA A partial agonist, in humans

British journal of anaesthesia : BJA, 2019-08, Vol.123 (2), p.e194

2019

Volltextzugriff (PDF)

Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial

Journal of psychopharmacology (Oxford), 2020-09, Vol.34 (9), p.1030-1042

2020

Volltextzugriff (PDF)

Lack of Detection of the Analgesic Properties of PF‐05089771, a Selective Nav1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects

Clinical and translational science, 2020-03, Vol.13 (2), p.318-324

2020

Volltextzugriff (PDF)

Early removal of the chest tube after complete video-assisted thoracoscopic lobectomies

European journal of cardio-thoracic surgery, 2011-04, Vol.39 (4), p.575-578

2011

Volltextzugriff (PDF)

Overuse of Imaging the Male Breast-Findings in 557 Patients

The breast journal, 2015-05, Vol.21 (3), p.219-223

2015

Volltextzugriff (PDF)

Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus

Journal of cosmetic dermatology, 2020-11, Vol.19 (11), p.2845-2858

2020

Volltextzugriff (PDF)

Demonstration of an anti‐hyperalgesic effect of a novel pan‐Trk inhibitor PF‐06273340 in a battery of human evoked pain models

British journal of clinical pharmacology, 2018-02, Vol.84 (2), p.301-309

2018

Volltextzugriff (PDF)

Lack of Detection of the Analgesic Properties of PF-05089771, a Selective Na v 1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects

Clinical and translational science, 2020-03, Vol.13 (2), p.318-324

2020

Volltextzugriff (PDF)

Lack of Detection of the Analgesic Properties of PF-05089771, a Selective Nav 1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects

Clinical and translational science, 2020-03, Vol.13 (2), p.318-324

2020

Volltextzugriff (PDF)

Extremities: Foot rejuvenation

Calcium Hydroxylapatite Soft Tissue Fillers, 2021, p.153-154

1, 2021

Volltextzugriff (PDF)

Neck and chest: Skin rejuvenation of the breast

Calcium Hydroxylapatite Soft Tissue Fillers, 2021, p.123-125

1, 2021

Volltextzugriff (PDF)

Neck and chest: Skin rejuvenation of the décolletage

Calcium Hydroxylapatite Soft Tissue Fillers, 2021, p.119-121

1, 2021

Volltextzugriff (PDF)

Complication management and prevention

Calcium Hydroxylapatite Soft Tissue Fillers, 2021, p.169-180

1, 2021

Volltextzugriff (PDF)

Extremities: Upper leg skin quality improvement

Calcium Hydroxylapatite Soft Tissue Fillers, 2021, p.147-149

1, 2021

Volltextzugriff (PDF)

Neck and chest: Rejuvenation of abdominal skin

Calcium Hydroxylapatite Soft Tissue Fillers, 2021, p.127-129

1, 2021

Volltextzugriff (PDF)

Extremities: Calf augmentation

Calcium Hydroxylapatite Soft Tissue Fillers, 2021, p.151-152

1, 2021

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(18)
Buchkapitel
(12)

Sprache

Englisch
(30)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective NaV1.8 Inhibitor, in Healthy Male Adults

A phase I, randomized, double‐blind, placebo‐controlled, single‐ and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX‐128, a highly selective Nav1.8 inhibitor, in healthy adults

Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABAA partial agonist, in humans

Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugs

A phase I, randomized, double-blind, placebo-controlled, single- and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX-128, a highly selective Na v 1.8 inhibitor, in healthy adults

The ultraviolet B inflammation model: Postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjects

A split‐face comparative performance evaluation of injectable hyaluronic acid‐based preparations HCC and CPM‐HA20G in healthy females

Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteers

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective [Na.sub.V]18 Inhibitor, in Healthy Male Adults

Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABA A partial agonist, in humans

Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial

Lack of Detection of the Analgesic Properties of PF‐05089771, a Selective Nav1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects

Early removal of the chest tube after complete video-assisted thoracoscopic lobectomies

Overuse of Imaging the Male Breast-Findings in 557 Patients

Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus

Demonstration of an anti‐hyperalgesic effect of a novel pan‐Trk inhibitor PF‐06273340 in a battery of human evoked pain models

Lack of Detection of the Analgesic Properties of PF-05089771, a Selective Na v 1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects

Lack of Detection of the Analgesic Properties of PF-05089771, a Selective Nav 1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects

Extremities: Foot rejuvenation

Neck and chest: Skin rejuvenation of the breast

Neck and chest: Skin rejuvenation of the décolletage

Complication management and prevention

Extremities: Upper leg skin quality improvement

Neck and chest: Rejuvenation of abdominal skin

Extremities: Calf augmentation

Suchergebnisse filtern